Bluejay Diagnostics, Inc. Cash Equivalents, at Carrying Value
Bluejay Diagnostics, Inc. (BJDX) had Cash Equivalents, at Carrying Value of $2.33 million as of 2021-09-30, per its 10-Q filed 2021-12-16.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash and Cash Equivalent
us-gaap:CashEquivalentsAtCarryingValue · last filed 2021-12-16
- 2021-09-30: Cash Equivalents, at Carrying Value $2.33M.
- 2020-12-31: Cash Equivalents, at Carrying Value $912.36K.
- 2020-09-30: Cash Equivalents, at Carrying Value $72.77K.
- 2019-12-31: Cash Equivalents, at Carrying Value $96.01K.
| Period end | Cash Equivalents, at Carrying Value |
|---|---|
| 2021-09-30 | $2.33M 10-Q · filed 2021-12-16 |
| 2020-12-31 | $912.36K 10-Q · filed 2021-12-16 |
| 2020-09-30 | $72.77K 10-Q · filed 2021-12-16 |
| 2019-12-31 | $96.01K 10-Q · filed 2021-12-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |